BiomX stockholders approve share issuance above 19.99% threshold for financing

BiomX Inc.

At special meeting on March 11, 2026, stockholders approved issuance of common shares exceeding 19.99% of outstanding for conversion of Series Y preferred and warrants.
Proposal 1 received 528,511 votes for, 23,714 against, and 4,753 abstentions.
Proposal 2 (adjournment) received 524,578 for, 31,778 against, and 622 abstentions; adjournment not needed.
Record date was Feb 3, 2026; 1,593,516 shares of common stock outstanding and entitled to vote.
Approval relates to a securities purchase agreement dated Dec 26, 2025 and engagement with H.C. Wainwright & Co.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.